Skip to main content

Core Scientific, Inc./tx

For the period ended Sep 30, 2026. Filed Nov 5, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2026 · Filed Nov 5, 2026

CORZ$12.72+8.2%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

5 — Balance Sheet Components

  1. BALANCE SHEET COMPONENTS

Customer funding receivable represents amounts due from CoreWeave for construction-related payables and accrued expenses incurred on its behalf. The Company collects these amounts from CoreWeave prior to payment to vendors. As of September 30, 2026 and December 31, 2025, the customer funding receivable totaled $282.7 million and $337.2 million, respectively. Obligations related to customer items are paid soon after reimbursement. As of September 30, 2026, $250.6 million of the related obligations were included in accrued expenses and $32.1 million were included in accounts payable, compared to $290.6 million in accrued expenses and $46.6 million in accounts payable as of December 31, 2025.

The customer funding receivable is presented net of an allowance for credit losses. The Company evaluates the collectibility of the customer funding receivable under the current expected credit loss model in accordance with ASC 326 and has determined that no allowance for credit losses was required as of September 30, 2026 or December 31, 2025.

Other current assets consisted of the following at the dates indicated (in thousands):

September 30, 2026December 31, 2025
Assets held for sale$29,709$—
Prepaid expenses34,93519,514
Other66,4715,487
Total other current assets$131,115$25,001

Accrued expenses consisted of the following at the dates indicated (in thousands):

September 30, 2026December 31, 2025
Accrued customer funded construction$250,596$290,603
Accrued capital expenditures352,990197,888
Accrued interest104,1604,600
Other71,77418,866
Total accrued expenses$779,520$511,957
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.